Pharmacotherapy Personalization of Cancer Patients

Status Completed

Clinical Trial Summary

Treatment personalization could ensure better outcome than standard procedures. It is particularly important in intensive care units where patients received many drugs and procedures. Their health status can change very fast. The oncologic patients treated in intensive care units are a special group of patients. Factors related to cancer influence extra their health status. The aim of this study is population pharmacokinetic-pharmacodynamic analysis drugs that are routinely used during an analgosedation in ICU oncologic patients. Analgosedation is monitored by drugs plasma concentration, the depth of sedation (bispectral index) and vital parameters like: systolic and diastolic blood pressure, mean arterial pressure, heart rate. Moreover, the TNM Staging System, biochemical parameters, The American Society of Anesthesiologists (ASA) physical status classification will be checked like potential factors influencing on pharmacokinetics and pharmacodynamics drugs used in the study.

Clinical Trial Description

The oncologic patients are qualified to head and neck tumor resection in general anesthesia. The anesthesia introduction is performed with single dose of midazolam, fentanyl, rocuronium and propofol/etomidate. Sevoflurane is used in anesthesia maintenance. Patients are transported to ICU after operation. Then they are kept for several hours in analgosedation. All used drugs are given by intravenous continuous infusion. Oxycodone is an analgesic component of analgosedation. Midazolam, dexmedetomidine and/or propofol are used as sedatives (2-3 drugs in every patient). Whole blood samples (2.0 ml) are collected during the study to measure drugs concentrations - 3-4 times during infusion, 5, 10, 15, 30, 60 minutes and 2, 4, 6 hours after the infusion cessation. Vital parameters and bispectral index are monitored during analgosedation and 6 hours after the infusion cessation and noted every 15-60 minutes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04866498
Study type	Observational
Source	Poznan University of Medical Sciences
Contact
Status	Completed
Phase
Start date	July 1, 2016
Completion date	March 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05980598` - TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma	Phase 2
Completed	`NCT02548377` - Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial	N/A
Active, not recruiting	`NCT02229656` - Olaparib and Radiotherapy in Head and Neck Cancer	Phase 1
Not yet recruiting	`NCT06347185` - Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study	N/A
Not yet recruiting	`NCT06289049` - Heavy Strength Training in Head and Neck Cancer Survivors	Phase 2
Terminated	`NCT02975739` - Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors	N/A
Recruiting	`NCT00982436` - Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer	Phase 1/Phase 2
Completed	`NCT01025518` - DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients	N/A
Active, not recruiting	`NCT00248235` - Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer	Phase 2/Phase 3
Terminated	`NCT00073450` - Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)	Phase 2
Completed	`NCT00135161` - Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer	Phase 1
Not yet recruiting	`NCT06458517` - Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers	N/A
Completed	`NCT05269342` - Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer	N/A
Recruiting	`NCT05544136` - A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer	Phase 2
Terminated	`NCT03286972` - PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
Recruiting	`NCT04435938` - A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck	Phase 2
Recruiting	`NCT03678649` - A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC	Phase 2
Recruiting	`NCT03975465` - EMST and Swallowing in Long-Term Survivors of HNCA	N/A
Completed	`NCT06446570` - Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma	Phase 2
Completed	`NCT03292250` - Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]	Phase 2